UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer

Frontiers in oncology, 2021-03, Vol.11, p.634059-634059

2021

Volltextzugriff (PDF)

Value of N1 Lymph Node Examination in the Prognosis of Patients With pT1-3N0M0 Non-Small Cell Lung Cancer

Frontiers in oncology, 2020-12, Vol.10, p.603378-603378

2020

Volltextzugriff (PDF)

Comparison of Perioperative Outcomes Between Precise and Routine Segmentectomy for Patients With Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: A Propensity Score-Matched Study

Frontiers in oncology, 2021-04, Vol.11, p.661821-661821

2021

Volltextzugriff (PDF)

Uniportal versus three‐port video‐assisted thoracoscopic surgery for non‐small cell lung cancer: A retrospective study

Thoracic cancer, 2021-04, Vol.12 (8), p.1147-1153

2021

Volltextzugriff (PDF)

Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus

Thoracic cancer, 2020-05, Vol.11 (5), p.1309-1318

2020

Volltextzugriff (PDF)

Minimally invasive versus open esophagectomy for resectable thoracic esophageal cancer (NST 1502): a multicenter prospective cohort study

Journal of the National Cancer Center, 2023-06, Vol.3 (2), p.106-114

2023

Volltextzugriff (PDF)

Prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis

Thoracic cancer, 2018-09, Vol.9 (9), p.1129-1135

2018

Volltextzugriff (PDF)

The preparation of anti-hnRNP A2/B1 polyclonal antibody and its potential application in non-small cell lung cancer

The Chinese-German journal of clinical oncology, 2008-05, Vol.7 (5), p.249-253

2008

Volltextzugriff (PDF)

ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas

Cancer Immunology, Immunotherapy, 2022-03, Vol.71 (3), p.645-660

2022

Volltextzugriff (PDF)

Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia

Leukemia, 2020-12, Vol.34 (12), p.3359-3369

2020

Volltextzugriff (PDF)

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future

Frontiers in oncology, 2022-08, Vol.12, p.976557-976557

2022

Volltextzugriff (PDF)

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

Cancer cell international, 2021-02, Vol.21 (1), p.103-103, Article 103

2021

Volltextzugriff (PDF)

Prognostic value of circulating tumor DNA in lymphoma: a meta-analysis

Clinical and experimental medicine, 2022-02, Vol.22 (1), p.1-7

2022

Volltextzugriff (PDF)

Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma

Frontiers in oncology, 2020-10, Vol.10, p.541401-541401

2020

Volltextzugriff (PDF)

Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial

Journal of clinical oncology, 2023-10, Vol.41 (29), p.4632-4642

2023

Volltextzugriff (PDF)

Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes

Blood cancer journal (New York), 2021-12, Vol.11 (12), p.195-195, Article 195

2021

Volltextzugriff (PDF)

Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies

Clinical lymphoma, myeloma and leukemia, 2022-02, Vol.22 (2), p.e77-e88

2022

Volltextzugriff (PDF)

Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Frontiers in oncology, 2021-09, Vol.11, p.739561-739561

2021

Volltextzugriff (PDF)

Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study

Blood cancer journal (New York), 2022-06, Vol.12 (6), p.92-92, Article 92

2022

Volltextzugriff (PDF)

Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience

Cancer medicine (Malden, MA), 2019-11, Vol.8 (15), p.6549-6558

2019

Volltextzugriff (PDF)

Transcription factor PU.1 is involved in the progression of glioma

Oncology letters, 2018-03, Vol.15 (3), p.3753-3759

2018

Volltextzugriff (PDF)

Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation

Oncoimmunology, 2016-05, Vol.5 (5), p.e1139274-e1139274

2016

Volltextzugriff (PDF)

Current evidences on the XPG Asp1104His polymorphism and melanoma susceptibility: a meta-analysis based on case–control studies

Molecular genetics and genomics : MGG, 2015-02, Vol.290 (1), p.273-279

2015

Volltextzugriff (PDF)

Increased susceptibility of tumorigenicity and decreased anti-tumor effect of DC vaccination in aged mice are potentially associated with increased number of NK1.1+CD3+ NKT cells

Experimental oncology, 2005-06, Vol.27 (2), p.125

2005

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor Immune Microenvironment Characteristics and Their Prognostic Value in Non-Small-Cell Lung Cancer

Value of N1 Lymph Node Examination in the Prognosis of Patients With pT1-3N0M0 Non-Small Cell Lung Cancer

Comparison of Perioperative Outcomes Between Precise and Routine Segmentectomy for Patients With Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: A Propensity Score-Matched Study

Uniportal versus three‐port video‐assisted thoracoscopic surgery for non‐small cell lung cancer: A retrospective study

Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus

Minimally invasive versus open esophagectomy for resectable thoracic esophageal cancer (NST 1502): a multicenter prospective cohort study

Prognostic value of the number of negative lymph nodes in esophageal carcinoma without lymphatic metastasis

The preparation of anti-hnRNP A2/B1 polyclonal antibody and its potential application in non-small cell lung cancer

ITGB2 as a prognostic indicator and a predictive marker for immunotherapy in gliomas

Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia

Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy

Prognostic value of circulating tumor DNA in lymphoma: a meta-analysis

Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma

Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation: A Multicenter Randomized Phase III Trial

Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomes

Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies

Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Haploidentical vs matched sibling donor transplant for paroxysmal nocturnal haemoglobinuria: A multicenter study

Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience

Transcription factor PU.1 is involved in the progression of glioma

Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation

Current evidences on the XPG Asp1104His polymorphism and melanoma susceptibility: a meta-analysis based on case–control studies

Increased susceptibility of tumorigenicity and decreased anti-tumor effect of DC vaccination in aged mice are potentially associated with increased number of NK1.1+CD3+ NKT cells

Aktive Filter

Suchergebnisse filtern